You're reading the free version. Trader adds the live tape and alerts.
Start tracking
XGN Sale Disclosure
Aballi John · SEC Form 4 · Filed Oct 19, 2026
Sale
Calculated transaction value
$269.79K
Aballi John President And CEO
XGN
Exagen Inc
XGN
Transaction date
Oct 16, 2026
Public filing date
Oct 19, 2026
Filing lag
Filed 3 days later
XGN daily price context
Close on/before transaction
$7.72
Oct 16, 2026
First close after public filing
$7.41
Oct 20, 2026
Return after filing · so far
-32.05%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 34,294 shares @ $7.87
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001843113-26-000009
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$269.79K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Exagen Inc. XGN Current | Sale | Oct 16, 2026 | $269.79K |